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Abstract
Background—Craniofacial microsomia (CFM) is a congenital condition characterized by
microtia and mandibular underdevelopment. Healthcare databases and birth defects surveillance
programs could be used to improve knowledge of CFM. However, no specific ICD-9-CM code
exists for this condition, which makes standardized data collection challenging. Our aim was to
evaluate the validity of existing ICD-9-CM codes to identify individuals with CFM.
Methods—Study sample eligibility criteria were developed by an expert panel and matched to 11
ICD-9-CM codes. We queried hospital discharge data from two craniofacial centers and identified
a total of 12,254 individuals who had ≥ 1 potentially CFM-related code(s). We reviewed all
(n=799) medical records identified at the University of North Carolina (UNC) and 500 randomly
selected records at Seattle Children’s Hospital (SCH). Individuals were classified as a CFM case
or non-case.
Results—Thirty-two individuals (6%) at SCH and 93 (12%) at UNC met the CFM eligibility
criteria. At both centers, 59% of cases and 95% of non-cases had only one code assigned. At both
centers, the most frequent codes were 744.23 (microtia), 754.0 and 756.0 (nonspecific codes), and
the code 744.23 had a positive predictive value (PPV) >80% and sensitivity >70%. The code
754.0 had a sensitivity of 3% (PPV<1%) at SCH and 36% (PPV=5%) at UNC, whereas 756.0 had
a sensitivity of 38% (PPV=5%) at SCH and 18% (PPV=26%) at UNC.
Conclusions—These findings suggest the need for a specific CFM code to facilitate CFM
surveillance and research.
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Introduction
Craniofacial microsomia (CFM) is a congenital condition characterized by
underdevelopment of the ear (microtia and anotia) and mandible, and often includes
extracranial anomalies (Gorlin et al., 2001). Wide phenotypic variation is characteristic of
CFM, and microtia has been considered a mild form (Bennun et al., 1985; Grabb, 1965;
Melnick, 1979; Rollnick and Kaye, 1983; Tasse et al., 2007). Though CFM is typically
associated with facial asymmetry, bilateral involvement has been reported in a high
proportion of individuals with CFM (Heike and Hing, 2009). The etiology of this condition
is unknown, and CFM remains a clinical diagnosis, though there are no established clinical
diagnostic criteria for CFM. We use the term CFM to encompass other terms that have been
used interchangeably for the same phenotype, including hemifacial microsomia, Goldenhar
syndrome, and oculo-auricular-vertebral spectrum. The estimated birth prevalence of this
highly heterogeneous condition is 1 in 5,600 live births (Cohen et al., 1989; Grabb, 1965),
making it the third most common congenital craniofacial condition. Craniofacial microsomia
often affects breathing, hearing, dental occlusion and speech. According to published
guidelines, children with CFM require longitudinal, multidisciplinary health care (Brent,
1999; Heike and Hing, 2009; Monahan et al., 2001). Despite its clinical importance in terms
of frequency, impact on health and functioning, and burden of care, there are no
International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM)
codes specific to CFM.
Lack of such a code has been a barrier to effective surveillance of and research on CFM,
resulting in a dearth of literature regarding CFM etiology, clinical course, health care
services, and quality of life for individuals with this condition. With the use of a specific
CFM code, these areas of inquiry could be explored through hospital discharge databases,
national healthcare databases, and birth defects surveillance programs. Multicenter
collaborations are needed to conduct rigorous epidemiologic studies regarding possible risk
factors, yet such investigations require standardized case ascertainment procedures. Data
collection standardization can be greatly enhanced by incorporating relevant and specific
diagnostic codes.
Given the current lack of a specific CFM ICD-9-CM code and no plans to incorporate such a
code in the new ICD-10, reaching consensus on the most applicable code(s) would be a first
step to determine if any of the current ICD-9-CM codes are practical for CFM case
ascertainment. In addition, determining specific codes for CFM would facilitate surveillance
of and research on this condition. Our study objective was to estimate the sensitivity and
positive predictive value of selected ICD-9-CM codes for the identification of individuals
with CFM.
Methods
This study was conducted through a multicenter consortium entitled the “Facial Asymmetry
Collaborative for Interdisciplinary Assessment and Learning (FACIAL).” The FACIAL
network was supported by the National Institute of Dental and Craniofacial Research to
address gaps in knowledge regarding the etiology and care for children with CFM. FACIAL
presently consists of four U.S. craniofacial centers. The network’s first tasks were to
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develop a consensus-based research definition of CFM and to delineate specific case
eligibility criteria. The expert panel, convened for these purposes, included team members
from several U.S. craniofacial centers and included: craniofacial pediatricians, dentists,
epidemiologists, medical geneticists, oral and maxillofacial surgeons, orthodontists,
otolaryngologists, and plastic and reconstructive surgeons with experience in the diagnosis
and care of children with CFM.
The craniofacial features associated with CFM range from subtle mandibular asymmetry
with a preauricular skin tag to more severe forms that include microtia, absence of the ear
canal, facial clefts, and/or epibulbar dermoids. An exhaustive list of CFM features was
compiled and discussed at an in-person FACIAL network meeting and the resulting
consensus led to the eligibility criteria. The CFM case inclusion criteria were defined as at
least one of the following: 1) microtia; 2) anotia; 3) facial asymmetry and preauricular tag;
4) facial asymmetry and facial tag; 5) facial asymmetry and epibulbar dermoid; 6) facial
asymmetry and macrostomia; 7) preauricular tag and epibulbar dermoid; 8) preauricular tag
and macrostomia; 9) facial tag and epibulbar dermoid; 10) macrostomia and epibulbar
dermoid.. Clinical features of mandibular hypoplasia, soft tissue deficiency, facial nerve
palsies, and/or orbital dystopia were categorized under facial asymmetry, unless individual
had clear indication of symmetric involvement. Our consensus panel agreed that children
with bilateral CFM are typically asymmetrically affected. Malformations associated with
CFM can be seen in other, well-known syndromes and in individuals with chromosomal
abnormalities. We excluded potential cases with a syndromic diagnosis (e.g. Treacher
Collins syndrome) or chromosomal abnormality in order to restrict our study population to
individuals with CFM of unknown etiology.
We generated an exhaustive list of ICD-9-CM codes that could potentially capture
individuals with the CFM inclusion criteria. Nine ICD-9-CM codes specifically matched at
least one inclusion criterion (Table 1). We also included two additional ICD-9-CM codes,
756.0 (“congenital anomalies of skull and face bones”) and 754.0 (“musculoskeletal
deformities of skull face and jaw”), used by providers for patients with CFM, although these
codes are less specific. Henceforth, we refer to all of these identified codes as “CFM codes.”
The current study was conducted at two craniofacial centers, Seattle Children’s Hospital
Craniofacial Center (SCH) and University of North Carolina Craniofacial Center (UNC). To
identify individuals who might carry a CFM diagnosis, we queried the inpatient and
outpatient billing databases for the longest period available for electronic billing records
through each institution: (1) SCH between October 1, 1997 to September 30, 2011 and (2)
UNC between July 1, 2004 and January 18, 2011. Specifically, the queries identified any
patient seen at either hospital who had received one or more of the CFM codes. This search
yielded a total of 11,455 unique patients at SCH and 799 at UNC.
The main outcomes were the sensitivity and positive predictive value for ascertaining CFM
by using the CFM codes, in isolation and in combination. We abstracted medical records
from patients ascertained in this manner, reviewing all 799 medical records identified at
UNC and 500 records randomly selected from the 11,455 patients identified at SCH using a
formally designed and structured abstraction form. A trained healthcare professional (CLH
and DV) from each center reviewed each medical chart at her respective institution and
recorded any clinical descriptions that corresponded to the list of CFM eligibility criteria.
We classified individuals as having a CFM diagnosis (case) or not (non-case) based on
whether individuals met the eligibility criteria.
We then compared the CFM codes identified in the records of those who met the CFM
eligibility criteria and those who did not. We summarized the distribution of number of
Luquetti et al. Page 3










codes per individual. We also calculated the sensitivity and positive predictive values and
corresponding 95% confidence intervals (CI) for each code and code combination. The
sensitivity of each ICD-9-CM code was defined as the number of CFM cases who had the
respective code in the billing data divided by the number of CFM cases overall. Positive
predictive value was calculated as the proportion of individuals with a particular ICD-9-CM
code who met CFM case criteria. We were unable to calculate the specificity and negative
predictive value given a lack of information on the number of individuals in the respective
databases without CFM codes and without a diagnosis of CFM.
The codes 743.8 and 744.21 were never used in the UNC data nor in the records selected for
review at SCH. In order to assess the sensitivity of these codes for ascertaining CFM, we
reviewed the medical records of the 31 individuals among the total 11,455 individuals with
CFM codes at SCH that had these codes.
We performed all analyses in Stata version 10.1 (StataCorp, 2007). Institutional Review
Board (IRB) approval was obtained for all study procedures at Seattle Children’s Research
Institute IRB and UNC Biomedical IRB.
Results
For the 500 individuals included in the medical chart abstraction at SCH, 58% were male.
For the 799 individuals at UNC, 525 (64%) were male. The distribution of CFM codes was
similar among sampled and non-sampled patients at SCH.
At UNC, 93 individuals (12%) met the CFM eligibility criteria, whereas 32 (6%) met the
CFM eligibility criteria in the SCH sample. Overall, the codes most frequently identified
included the two non-specific craniofacial codes, 754.0 and 756.0, and the code for microtia,
744.23 (Table 2). The codes for other specified congenital anomalies of the eye (743.8),
congenital absence of external ear (744.01), accessory auricle (744.1), and congenital
absence of ear lobe (744.21) were not identified in records at UNC. At SCH, codes 743.8
and 744.21 were also not identified in the sample of 500 records and in only 26 and 5,
respectively, of the total 11,455 records queried at SCH. Review of charts for these 31
records revealed that only one individual (with 744.21 code) met the case eligibility criteria.
At both centers, 59% of cases had only one code assigned compared with over 95% of non-
cases. The code for microtia (744.23) was frequently included in records of cases with two
CFM codes. At SCH, the most common additional codes were those for “other congenital
anomalies of external ear with impairment of hearing” (744.02) and anotia (744.01). At
UNC, the most common additional codes were the non-specific 754.0 and 756.0 (Table 2).
The microtia code (744.23) was the most frequently identified code among cases with 72%
and 82% at SCH and UNC, respectively. The positive predictive value for this code was
above 80% in both centers. The code 754.0 had a sensitivity of 3% (95% CI: 0–16) at SCH
and 35.5% (95% CI: 26–46) at UNC, whereas the code 756.0 had a sensitivity of 38% (95%
CI: 21–56) at SCH and 18% (95% CI: 11–28) at UNC. Though 756.0 had a positive
predictive value of 26% (95% CI: 16–39) at UNC, the positive predictive value for 756.0 at
SCH was only 5% (95% CI: 3–9). Positive predictive values were less than or equal to 5%
for 754.0 at both centers. At SCH, codes 744.01 and 744.1 had sensitivities of 19% (95% CI:
7–36) and 6% (95% CI: 1–21), respectively (Table 2).
The vast majority of non-cases had CFM codes 754.0 and/or 756.0. The diagnosis of skull
deformity was the most common condition identified from medical charts of non-cases.
Other diagnoses included: dysmorphic features, macrocephaly, known syndromes, and
craniosynostosis. We identified 14 and 20 individuals at UNC and SCH, respectively, for
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whom there was no clear explanation in the medical chart for the associated CFM code.
Non-cases identified by the 744.23 code either had a syndrome involving microtia (e.g.,
Treacher Collins) or were individuals with anomalies of the ear that are not by definition
considered microtia (e.g.: small ears) (Table 3)..
Discussion
Ascertainment of cases with congenital anomalies using ICD-9-CM codes is common in
epidemiologic studies (Frohnert et al., 2005; Frohnert et al., 2005; Juhn et al., 2011; Quan et
al., 2008; Rasmussen and Moore, 2001) and in birth defects surveillance systems reliant on
passive case ascertainment methods, e.g., by linking hospital discharge records, vital
statistics, or other administrative data (NBDPN, 2011; Rasmussen and Moore, 2001).
Standardized methods for population-based ascertainment have not yet been widely used in
CFM research. This is likely attributable to the lack of (1) diagnostic criteria for CFM and
(2) ICD codes with high sensitivity and positive predictive values. The absence of a specific
ICD-9-CM code for CFM could result in under- or overestimation of cases depending on the
ICD-9-CM codes chosen for a given study.
Ideally, ascertainment of cases of CFM through healthcare databases and birth defects
surveillance programs could be accomplished using one or more code combinations with
high sensitivity and specificity. To help address this issue, modifications to the 1979 British
Pediatric Association (BPA) Classification of Diseases and the World Health Organization’s
1979 ICD-9-CM codes for birth defects were made by the Division of Birth Defects and
Developmental Disabilities, National Center on Birth Defects and Developmental
Disabilities, Centers for Disease Control and Prevention (CDC, 2007). These more specific
codes are now employed by many active birth defects surveillance programs. Unfortunately,
these codes are not widely used by healthcare facilities in the U.S.
In this study, the heterogeneity we observed in a systematic review of charts from two
craniofacial centers suggests that ICD-9-CM codes, even in combination, do not appear to
have sufficiently high sensitivity and positive predictive value to be used as the sole method
of CFM case ascertainment for studies regarding CFM. Previous reports regarding the
validity of ICD-9-CM codes for other birth defects, such as congenital heart disease, have
also identified low sensitivity and a high false positive rate (Frohnert et al., 2005; Juhn et al.,
2011; Quan et al., 2008; Rasmussen and Moore, 2001). Therefore, data ascertained through
ICD-9-CM codes still require validation of clinical phenotypes through direct evaluation or
medical record review by trained medical and health care professionals for studies when an
accurate diagnosis is essential. This would not be a significant limitation if cases represented
a high percentage of records flagged for review. However, this percentage was 12% or less
at both centers, which suggests that the added requirement for a validation process may
make this ascertainment method costly and inefficient.
Given the absence of a specific diagnostic code for CFM, the heterogeneity in coding
practices we observed among medical centers is understandable, since centers or individual
practitioners must subjectively decide which code fits best. These judgments appropriately
differ depending on the patients’ specific CFM-related features, such as for patients with and
without microtia. In addition, while some practitioners will code every feature present in the
patient, others will chose codes based on severity of the anomalies, or the indication for the
current clinic visit. For example, a surgeon planning an ear reconstruction for a patient
would likely chose the code for microtia, while another surgeon who operates on the same
patient to repair a lateral oral cleft may opt to use the code for macrostomia.
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A potential limitation of this study is that healthcare providers who care for CFM patients
might assign ICD-9-CM codes other than those we evaluated. We relied on an expert panel
of subspecialists who care for patients with CFM at craniofacial centers across the U.S. to
determine the CFM eligibility criteria and identification of ICD-9-CM codes used for CFM.
Our panel included clinicians from UNC and SCH to identify the most common codes they
and their colleagues have used to denote CFM or its features. In addition, we thoroughly
searched the ICD-9-CM for additional codes that could match the eligibility criteria. Thus,
although use of other codes would mean some CFM cases could have been missed, it is
unlikely that any other codes were used in a sufficiently high proportion to invalidate the
study results. Indeed, such further variability supports the conclusion that a specific code is
needed.
Including more centers in the study may have provided additional insight into the variability
of coding by different centers. However, both craniofacial centers provide care for a large
population of children with CFM and have an interdisciplinary model of care with multiple
professionals assigning codes for patients. Therefore, we captured a wide range of codes
used for CFM, and again, adding centers would only have increased the already high
heterogeneity.
Making a diagnosis of CFM relying solely on the medical chart review can be challenging
because the gold standard for any diagnosis is the medical examination. Because we did not
perform physical examinations, it is possible that some CFM patients were misclassified as
non-cases. This could have happened if, for example, a patient with facial asymmetry also
had an unreported epibulbar dermoid. Although we cannot disregard such misclassification
as a potential limitation, its impact on the study results was minimized by limiting the search
to hospitals with craniofacial centers.
This is the first study, to the best of our knowledge, to address the use of ICD-9-CM codes
for patients with CFM. A strength of the study was the development of a CFM case
definition by consensus among a large, diverse panel of experts. In addition, charts were
thoroughly reviewed by experienced providers by using a formally designed and structured
medical chart abstraction form. Both the CFM case definition and the structured abstraction
form are used in the FACIAL network studies and could potentially be used by other
research teams interested in CFM. We would share the chart abstraction form and other data
collection protocols to further CFM research efforts in other groups.
The study results suggest that ICD-9-CM code-based ascertainment of CFM might lead to
under- or overestimation of the prevalence of this condition, depending on which codes are
used. These results clearly indicate the need for a specific CFM code to facilitate CFM
surveillance and research. The ICD-10 system has already been adopted in several countries,
and the U.S. will incorporate this system into clinical billing systems in the near future.
Though the ICD-10 system includes much more specific codes for many conditions, it has
little impact on CFM coding. For instance, the new code Q87.0 “Congenital malformation
syndromes predominantly affecting facial appearance” is more specific than the ICD-9-CM
codes 756.0 and 754.0. It is recommended that this code be used for Goldenhar syndrome
and perhaps could be used to denote CFM more generally. The code remains non-specific,
however, and also includes unrelated conditions such as Moebius, oro-facial-digital, and
CHARGE syndromes. Thus relying on this new code would still require medical records
review to limit ascertainment specifically to CFM cases.
Even if a specific code for CFM were to be proposed immediately, it would not be
implemented for at least several years. Findings from this study suggest codes that might be
most efficient for surveillance and research on CFM (Table 4). Specifically, 744.01 (anotia)
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and 744.23 (microtia) presented with reasonable sensitivity and positive predictive value and
may be the most useful. Nevertheless, they cannot be the sole codes because many patients
have no ear abnormalities. Codes such as 754.0, 756.0 and 744.1 showed better positive
predictive value when used in combination and might be used for CFM patients in
combination with at least one other code to improve efficiency of case ascertainment
through ICD codes. The drawback of this approach is that only individuals assigned with
two or more codes (41% of CFM patients in our sample) would be ascertained in this way.
In summary, investigators should consider available resources, number of charts to be
reviewed, and study objectives in deciding which codes to include in the search.
We found that relatively labor-intensive, active ascertainment techniques are currently
needed to capture cases of CFM. Multiple codes are necessary because none of the ICD-9-
CM codes alone ascertained all infants with CFM. In addition, the high number of non-cases
resulting from a search based on the current ICD-9-CM codes demonstrated the need for
physician confirmation through medical records review. As there are limited resources
available for medical research and birth defects surveillance of CFM, such additional efforts
will often not be possible. Lack of specific ICD-9-CM codes for CFM will continue to
impede surveillance and research on this condition. The condition’s prevalence, clinical
relevance, and need for complex long-term healthcare warrant the development of a CFM-
specific diagnostic code.
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Table 1
Facial Asymmetry Collaborative for Interdisciplinary Assessment and Learning (FACIAL) craniofacial
microsomia: features included in case eligibility criteria and the corresponding ICD-9-CM codes.
Inclusion Criteria*‡ ICD-9-CM Code ICD-9-CM Description
Epibulbar dermoid 743.8 Other specified congenital anomalies (CAs)* of eye
Microtia/Anotia 744.0 CAs of ear causing impairment of hearing
744.01 Congenital absence external ear
744.02 Other CAs of external ear with impairment of hearing
744.09 Other CAs of ear causing impairment of hearing
744.21 Congenital absence of ear lobe
744.23 Microtia
Preauricular tag 744.1 Accessory auricle
Macrostomia 744.83 Macrostomia
Facial asymmetry 754.0 Musculoskeletal deformities of skull face and jaw
756.0 CAs of skull and face bones
Facial tag -------- ---------
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Table 3
Diagnoses of individuals that did not meet Facial Asymmetry Collaborative for Interdisciplinary Assessment
and Learning (FACIAL) craniofacial microsomia eligibility criteria
University of North Carolina Seattle Children’s Hospital
Diagnosis N (%) ICD-9-CM Codes N (%) ICD-9-CM Codes
Skull Deformity 493 (70) 744.83, 754.0, 756,0 213 (46) 754.0, 756.0
Dysmorphic features 6 (1) 754.0 46 (10) 744.1, 754.0, 756.0
Macrocephaly 4 (1) 754.0 49 (11) 754.0, 756.0
Known syndrome 33 (5) 744.02, 744.09, 744.23, 754.0, 756.0 39 (8) 744.02, 744.1, 744.23, 744.83, 754.0, 756.0
Craniosynostosis 54(7.6) 754.0, 756.0 30 (6) 754.0, 756.0
Ear anomaly, not microtia -- -- 8 (2) 744.01, 744.02, 744.1, 744.23, 756.0
Cleft lip and palate 15 (2) 754.0 9 (2) 754.0, 756.0
Cleft palate -- -- 3 (1) 754.0, 756.0
Robin sequence -- -- 9 (2) 754.0, 756.0
Facial asymmetry 28 (4) 754.0 4 (1) 754.0, 756.0
Preauricular tag 1 (0) 754.0 7 (2) 744.1
Preauricular pit 1 (0) 754.0 -- --
Epibulbar dermoid 1 (0) 754.0 -- --
Eye anomaly 6 (1) 754.0 -- --
Hearing loss 2 (0) 754.0 3 (1) 744.02, 754.0
Trauma 3 (0) 754.0 3 (1) 754.0, 756.0
Other 32 (5) 754.0 25 (5) 744.02, 744.1, 754.0, 756.0
Unknown 25 (4) 754.0 -- --
Miscode 14 (2) 754.0 20 (4) 744.1, 754.0, 756.0
Multiple codes are listed for some diagnoses because for these diagnoses, providers used one of several different ICD-9-CM codes; this is due to
the lack of specificity of ICD-9-CM codes for these conditions.
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Table 4
Utility of ICD-9-CM codes for identifying craniofacial microsomia (CFM) for surveillance and research
programs
ICD-9-CM code Proposed decisions for ascertainment ofCFM cases Rationale
743.8 No None met eligibility criteria
744.01 Yes Reasonable‡ sensitivity and positive predictive value at SCH
744.02 Yes Reasonable‡ sensitivity and positive predictive value at SCH and UNC
The combination with another CFM code* improves PPV**
744.09 No Only one individual assigned with this code met eligibility criteria
744.23 Yes High sensitivity and specificity
744.1 Yes, in combination with another CFM
code*
The combination with another CFM code* results in reasonable PPV at SCH
744.83 Yes High PPV at UNC
754.0 Yes Reasonable sensitivity at UNC
The combination with another CFM code* improves PPV
756.0 Yes Reasonable‡ sensitivity and PPV
The combination with another CFM code* improves PPV
*
For example: 744.23 or 756.0
**
PPV = positive predictive value
‡
Reasonable is defined as a value of >15% in at least one institution
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